Docusate Sodium
- Product NDC
- 45802-486
- 11-digit product format
- 458020486
- Labeler code
- 45802
- Product ID
- 45802-486_15d8cf99-c44d-459f-91ca-7fd089897869
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate sodium
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2008-10-28
- Substance
- DOCUSATE SODIUM
- Active strength
- 100 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOCUSATE SODIUM | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F05Q2T2JA0 |
| Rxcui | 1115005 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 45802-486-78 | Docusate Sodium | 100 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 100 | | 5 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DOCUSATE SODIUM | ACTIVE INGREDIENT | F05Q2T2JA0 | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| DOCUSATE | ACTIVE MOIETY | M7P27195AG | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| D&C RED NO. 33 | INACTIVE INGREDIENT | 9DBA0SBB0L | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| SORBITAN | INACTIVE INGREDIENT | 6O92ICV9RU | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PERRIGO NEW YORK INC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 45802-486 | DOCUSATE SODIUM CAPSULE, LIQUID FILLED [PADAGIS ISRAEL PHARMACEUTICALS LTD] | 5 | Current NDC, Legacy NDC, 1 package rows | 20240817_bce3b245-ec47-4e62-9cad-bb12d0812c18.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45802-486-78 | 45802048678 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (45802-486-78) | 2008-10-28 | 0000-00-00 | No | No | Current |